Is Oral Anticoagulation an Independent Predictor of Mortality in STEMI and High-Risk NSTEMI Patients After Primary PCI? A Propensity Score-Matched Retrospective Analysis
Cardiovascular Therapeutics, cilt.2026, sa.1, 2026 (SCI-Expanded, Scopus)
- Yayın Türü: Makale / Tam Makale
- Cilt numarası: 2026 Sayı: 1
- Basım Tarihi: 2026
- Doi Numarası: 10.1155/cdr/1295386
- Dergi Adı: Cardiovascular Therapeutics
- Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, BIOSIS, EMBASE, MEDLINE, Directory of Open Access Journals, Academic Search Ultimate (EBSCO), Biomedical Reference Collection: Corporate Edition (EBSCO), Health Research Premium Collection (ProQuest), Pharma Collection (ProQuest)
- Anahtar Kelimeler: antithrombotic therapy, long-term mortality, oral anticoagulation, primary percutaneous coronary intervention, ST-segment elevation myocardial infarction
- Sağlık Bilimleri Üniversitesi Adresli: Evet
Özet
Background: Managing STEMI and high-risk NSTEMI-equivalent patients on chronic oral anticoagulation (OAC) undergoing primary PCI poses competing ischaemic and bleeding risks. Methods: This single-centre retrospective study enrolled 604 consecutive STEMI/high-risk NSTEMI patients undergoing primary PCI (2012–2023). OAC users (n = 100) were compared with propensity score–matched controls (n = 203). Primary endpoints included all-cause mortality, bleeding, stroke, recurrent MI and rehospitalisation over a mean 3-year follow-up. Results: OAC users had a higher prevalence of prior ischaemic stroke/TIA (19% vs. 3%, p < 0.001) and known coronary artery disease (33% vs. 20%, p = 0.015). In-hospital mortality was comparable (7% vs. 5.9%, p = 0.80). Postdischarge long-term mortality was significantly higher in OAC users (31% vs. 14.8%, p = 0.001), as were access-site haematoma (8% vs. 2%, p = 0.02) and minor bleeding (7% vs. 1.5%, p = 0.03). On multivariable Cox regression, OAC use was not an independent mortality predictor (HR 0.81, 95% CI 0.47–1.37, p = 0.43); age, reduced ejection fraction and chronic kidney disease were the principal determinants. Conclusion: Despite higher postdischarge mortality and bleeding, OAC use was not independently associated with mortality after adjustment. Comorbidity burden drives prognosis, emphasising comprehensive risk stratification in this population.